Hematology and Oncology Discovery is a peer reviewed, open access journal on hematology and oncology research, spanning from basic laboratory, translational to clinical investigations. The journal aims to provide a platform for hematologists and oncologists to communicate practical experiences to facilitate real-case diagnosis and treatments as well as adoption of latest physiological and biological advances and new technologies derived, and to inspire researchers to tackle challenges from clinical settings. Besides original research, reviews, case studies and clinical trials, the journal is particularly interested in summary of individual opinion on specific disorder facilitating clinical practice.
The journal encourages clinicians and physicians to take a holistic and multidisciplinary angle when discussing their cases and in particular, when pursuing solutions for hematologic malignancies, tumors and complications:
- Gene therapy and application in patient care
- Immunotherapy and Immunobiology
- Transplantation
- Observations on pathological discoveries, e.g., molecular pathways, genomics etc.
- Rare diseases in hematology and oncology
Hematology and Oncology Discovery welcomes the submission of Original Research, Review, Case Report, Clinical Trial, Disease Treatment and Letters to the Editor.
Information for Contributors
The Journal will not consider papers that have been accepted for publication or published elsewhere. Our full requirements for submission, including our conflicts of interest disclosure and ethics policies are described in detail in our Publication Ethics and Malpractice Statement.
Submission Process
Submissions to Hematology and Oncology Discovery are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/hemoncdiscneeds
Disclosures
Each author must disclose all financial relationships related to the subject of the paper. This should include equity ownership, profit-sharing agreements, royalties, patents, and grants. Authors do not need to report the sums concerned. If none, state “none”.